Replimune Group, Inc. (REPL)
$13.25+0.76%Close
SELLRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-15
52-week IV5.1%–499.5%
- Market cap
- $1.1B
- Beta
- 0.94
- P/E (TTM)
- -4.21
- IV-%ile
- 22
- IV ATM
- 86.3%
- Short % float
- 29.35%
- Days to cover
- 11.1
- SI change
- -3.3%
- 1W
- +1.92%
- 1M
- -11.90%
- vs SPY 1W
- -0.03%
- vs SPY 1M
- -13.31%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$6.3BRECOVERYQ 8$14.15-8.41%
- MBXSELLMBX Biosciences, Inc. Common Stock$2.8BRECOVERYQ 40$58.54-2.77%
- VIRBUYVir Biotechnology, Inc.$2.0BRECOVERYQ 13$11.78-1.53%
- AVBPSELLArriVent BioPharma, Inc.$1.3BCRISISQ -8$28.46-46.98%
- MGTXSELLMeiraGTx Holdings plc$1.0BCRISISQ 6$10.92-2.93%
- DNABUYGinkgo Bioworks Holdings, Inc.$979MRECOVERYQ -17$14.98-17.16%
- ATXSAstria Therapeutics, Inc.$718M$12.58
- PRMESELLPrime Medicine, Inc.$580MRECOVERYQ -7$3.21+9.03%
- VALNSELLValneva SE$551MCRISISQ -0$5.82+0.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
